ZERO is committed to bridging the gap between racial and health disparities in prostate cancer among Black men. In order to achieve our mission to end prostate cancer, we must also zero out racial disparities in prostate cancer. Here are the troubling facts on how this disease impacts Black men:
- African American men are 1.8 times more likely to be diagnosed with prostate cancer than white men.
- African American men are 2.2 times more likely to die from—prostate cancer than white men.
- African American men are also slightly more likely than white men to be diagnosed with advanced disease.
- Only 33% of African American men over 50 years old have received a PSA test.
These statistics are a result of factors happening within the U.S. healthcare system including access to care issues, racial bias, and distrust in the medical system. ZERO’s Prostate Cancer Racial Disparities Task Force will help ZERO strengthen existing initiatives, identify new ways, and design solutions to further address these issues in a consistent and impactful manner. Below are the current members of our Task Force:
Chairman, ZERO Board of Directors
Kelvin Moses, M.D., Ph.D.
ZERO Board of Directors/Medical Advisory Board
Associate Professor of Urology
Vanderbilt University Medical Center
SVP, Chief Talent and Diversity Officer, TransUnion
Stanley Frencher, Jr., M.D., MPH
Director, Surgical Outcomes and Quality
MLK Outpatient Center
Los Angeles, CA
Arturo Holmes, II, M.D.
SUNY Downstate Health Sciences University
New York, NY
Producer, BlueChild Entertainment, LLC
Aliso Viejo, CA
Former CEO, Matthew Walker Comprehensive Health Center
Deacon Lyndon Nicholson
Zion Baptist Church
Rancho Santa Fe, CA
Ronald C. Small
Vice Chairman, 100 Black Men of Middle Tennessee
LaMonica Stewart, Ph.D.
Meharry Medical College
Read blog posts from our Task Force Co-Chairs on the stark contrasts between white and Black men in prostate cancer, and learn about how prostate cancer and COVID-19 similarly affect the Black community.